VisVivaToTheMoonThe willingness of NIDA to recommend *regulation* of recreational #cannabis is a big deal. As one of the key players in the ongoing HHS review of cannabis’ CSA scheduling, this report gives us a snapshot into the sorts of high-level input that might be driving the report’s thesis.
All indications are that a report will recommend substantial changes to cannabis’ scheduling. Based on many indicators, I fully expect cannabis to be removed from Schedule 1 after a report recommending to do so. Precisely where cannabis lands is still a mystery; the DEA very well could determine the CSA requires cannabis to remain as a Schedule 2 drug without legislative action. We’ll see.
I expect the report to come out this Summer or this Fall. When it was initiated in October, I estimated that such a study would take at least 8 months to undertake. Eight months later, here we are!
Change is slow but seemingly inevitable at this point. Hopefully medical #marijuana will be federally legal next year.
Top Federal Health Official Calls For ‘Regulating’ Marijuana Products—Which Is Only Possible Under Legalization
As states continue to legalize marijuana, it is “crucial” that cannabis products are regulated, a top federal health official says. National Institute on Drug Abuse (NIDA) Director Nora Volkow said that while it might be “ideal” if states slowed down on enacting reform, the fact is that “states are legalizing it,” and “what we need […]